• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IXC

INVEX THERAPEUTICS LTD - Corporate Spotlight

0.00% ! 8.3¢
Market Cap $6.237M  !

Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical... Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure. Our primary focus is on the orphan disease Idiopathic Intracranial Hypertension (IIH), a large and growing market opportunity with no regulatory cleared treatmentsMore

No Corporate Spotlight currently available.

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
8.3¢
Change
0.000(0.00%)
Mkt cap ! $6.237M
Open High Low Value Volume
8.3¢ 8.3¢ 8.3¢ $1.14K 13.73K

Buyers (Bids)

No. Vol. Price($)
1 28352 8.3¢
 

Sellers (Offers)

Price($) Vol. No.
9.7¢ 8998 1
View Market Depth
Last trade - 12.28pm 25/07/2025 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.